Schunkert H, Ingelfinger J R, Hirsch A T, Pinto Y, Remme W J, Jacob H, Dzau V J
Falk Cardiovascular Research Center, Stanford, Calif.
Circ Res. 1993 Feb;72(2):312-8. doi: 10.1161/01.res.72.2.312.
Although renin and angiotensinogen are known to be subject to feedback regulation, the effects of angiotensin II (Ang II) on the regulation of angiotensin converting enzyme (ACE) gene expression and enzymatic activity have not yet been studied. Therefore, the effects of exogenous Ang II infusion and ACE inhibition on ACE mRNA expression were examined. Ang II was infused intravenously in male Sprague-Dawley rats for 3 days at 100 (low dose), 300 (medium dose), or 1,000 (high dose) ng/kg per minute (n = 8 for each group). Compared with control (vehicle infusion, n = 8), Ang II infusion increased plasma Ang II concentration (62, 101, 126 [p < 0.05], and 187 [p < 0.05] fmol/ml) and mean arterial blood pressure (106, 119 [p < 0.05], 134 [p < 0.05], and 125 mm Hg for control, low, medium, and high doses, respectively). Ang II infusion decreased ACE mRNA levels in the lung (57%, 52%, and 51%; p < 0.05 for each) and testis (49%, 63%, and 53% of control for low, medium, and high doses, respectively; p < 0.05 for each), two major sites of ACE synthesis. There was, albeit less pronounced, a parallel decrease in pulmonary ACE activity (4.38, 3.92, 3.07 [p < 0.05], and 3.48 [p < 0.05] nM/mg per minute for control, medium, and high doses, respectively). In contrast, serum (54, 50, 48, and 38 [p < 0.05] nM/ml per minute) and testicular (2.63, 2.08 [p < 0.05], 2.24, and 2.18 nM/mg per minute for control, low, medium, and high doses, respectively) ACE activities displayed only minimal change in animals infused with Ang II.(ABSTRACT TRUNCATED AT 250 WORDS)
虽然已知肾素和血管紧张素原受反馈调节,但血管紧张素II(Ang II)对血管紧张素转换酶(ACE)基因表达和酶活性调节的影响尚未得到研究。因此,研究了外源性输注Ang II和抑制ACE对ACE mRNA表达的影响。以每分钟100(低剂量)、300(中剂量)或1000(高剂量)ng/kg的剂量对雄性Sprague-Dawley大鼠静脉输注Ang II,持续3天(每组n = 8)。与对照组(输注赋形剂,n = 8)相比,输注Ang II可提高血浆Ang II浓度(分别为62、101、126 [p < 0.05]和187 [p < 0.05] fmol/ml)以及平均动脉血压(对照组、低剂量组、中剂量组和高剂量组分别为106、119 [p < 0.05]、134 [p < 0.05]和125 mmHg)。输注Ang II可降低肺(分别降低57%、52%和51%;每组p < 0.05)和睾丸(低、中、高剂量组分别为对照组的49%、63%和53%;每组p < 0.05)中ACE mRNA水平,肺和睾丸是ACE合成的两个主要部位。肺ACE活性也有平行下降(尽管不太明显)(对照组、中剂量组和高剂量组分别为4.38、3.92、3.07 [p < 0.05]和3.48 [p < 0.05] nM/mg每分钟)。相比之下,在输注Ang II的动物中,血清(分别为54、50、48和38 [p < 0.05] nM/ml每分钟)和睾丸(对照组、低剂量组、中剂量组和高剂量组分别为2.63、2.08 [p < 0.05]、2.24和2.18 nM/mg每分钟)ACE活性仅显示出极小的变化。(摘要截短于250字)